> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Device Patient Preference Information
- URL: https://www.fdaweb.com/guide-on-device-patient-preference-information/
- Published: 2024-09-06T12:00:00.000Z
- Updated: 2026-09-14T14:40:38.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5157729

*Federal Register* notice: FDA is making available a draft guidance entitled “Incorporating Voluntary Patient Preference Information over the Total Product Life Cycle.” The document discusses the principal concepts that sponsors and other interested parties should consider when choosing to collect and submit patient preference information (PPI). The agency says the insight gathered from PPI could be used across the total product life cycle, including for reviewing IDEs,PMAs, 510(k)s, and de novo classification requests. The guidance also discusses FDA’s inclusion of PPI in its decision summaries and provides recommendations for the inclusion of such information in device labeling for certain devices. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2024-09-06/pdf/2024-20069.pdf?ref=fdaweb.com).